Monday, July 11, 2022 5:07:32 PM
What boggles my mind is how Relief Therapeutics allowed Dr. JJ control over zyesami & fda submissions. They should have gotten rid of him a long time ago. Maybe if they had ended their contract, Aviptadil would have had a chance! Also do you know if there is an appeal process for clinical trials? It's obvious that the nih trial was unfair in regard to length. I've tried reaching out to pulmonologist in India regarding aviptadil for my lungs. So far I've received no response. If anyone has suggestions, I'm all ears........
FEATURED Element79 Gold Corp Continues Fostering Local Community Engagement • Jun 4, 2024 9:08 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM